[Comparative immunohistochemistry study of different antibodies clones for detection of breast cancer markers (estrogen receptor, progesterone receptor, HER2/neu, Ki-67)]. / Sravnitel'noe issledovanie antitel razlichnykh klonov dlya vyyavleniya markerov raka molochnoi zhelezy (retseptorov estrogenov, progesterona, HER2/neu, Ki-67) immunogistokhimicheskim metodom.

OBJECTIVE: A comparative study of detection of breast cancer markers (estrogen receptors, progesterone receptors, HER2/neu, Ki-67) by immunohistochemical method with antibodies produced by PrimeBioMed (Russia) and antibodies produced by Roche Ventana (USA). MATERIAL AND METHODS: Surgical specimens and biopsies from 37 patients with invasive breast cancer were used. Sections were stained with antibodies of clones ER SP1 and GM030, PR 1E2 and PBM-5B8, HER2/neu 4B5 and PBM-46A6, Ki-67 30-9 and GM010. RESULTS: There was a high positive and significant correlation between the immunohistochemistry results and antibodies of the clones ER-SP1 and GM030, PR1E2 and PBM-5B8, HER2/neu4B5 and PBM-46A6, Ki-67 30-9 and GM010. CONCLUSION: The study showed the possibility of using antibodies of clones GM030, HER2/neu 4B5, PBM-46A6, GM010 (PrimeBioMed) on the Ventana Bench Marck Ultra automatic immunostainer using the detection system UltraView Universal DAB Detection Kit.

[Assessment of HER2 status of carcinomas of various localizations]. / Opredelenie HER2-statusa kartsinom razlichnykh lokalizatsii.

A detailed description of the methodological aspects of the evaluation of HER2-status in carcinomas of such localizations as the mammary gland, pancreas, salivary glands, stomach, colon, endometrium, bladder, lungs is presented. Approaches and criteria for assessing HER2 status from methodological and clinical points of view are analyzed. The data are systematized in tables for use in practical diagnostic work.

[Predictive markers of immunotherapy in cervical cancer]. / Prediktivnye markery immunoterapii v rake sheiki matki.

OBJECTIVE: Study of PD-L1 expression in squamous and adenosquamous cell cervical cancer (CC) by immunohistochemical (IHC) method, assessment of the relationship between PD-L1 tumor status and its clinical and morphological characteristics, TILs, MSI/dMMR, and HPV tumor status. MATERIAL AND METHODS: Surgical material was obtained from 41 patients with CC, on which the expression of PD-L1, proteins of the MMR system and p16 was studied by the IHC method, the TILs index was determined. RESULTS: Positive PD-L1 status was found in 51.2% of the studied CC samples. In the study sample, the level of PD-L1 expression depended on the severity of lymphoid infiltration of the tumor (p=0.038), it was shown that a positive PD-L1 status of CC can be expected with a TILs value greater than or equal to 50%. The age of the patients, the histological variant of the tumor, the pT and pN stage, the presence of lymphovascular invasion, and the HPV status did not statistically significantly affect the level of PD-L1 expression, however, there was an association between the PD-L1 status and the grade of CC malignancy (p=0.027). The presence of the MSI/dMMR phenomenon was detected in a small percentage of carcinomas (4.9%), the PD-L1 status of these tumors was determined as positive. CONCLUSION: A positive PD-L1 status is determined in a significant number of cases of CC, regardless of most of the studied clinical and morphological characteristics; there is a statistically significant relationship between PD-L1 expression and the degree of tumor differentiation and TILs. It has been shown that CC with the MSI/dMMR phenomenon is characterized by a positive PD-L1 status. The authors consider it necessary to study the expression of PD-L1 in patients with cervical carcinomas in order to determine the possibility of prescribing personalized therapy with immune checkpoint inhibitors.

[Updated CAP guidelines for determining molecular biological subtypes of breast cancer]. / Obnovlennye rekomendatsii CAP po opredeleniyu molekulyarno-biologicheskikh podtipov raka molochnoi zhelezy.

Updated 2023 guidelines from the College of American Pathologists (CAP) on immunohistochemical detection of human epidermal growth factor receptor type 2 (HER2), receptors of estrogen (ER) and progesterone (PgR), and the cell proliferation marker Ki-67 in breast cancer are presented. Attention is drawn to the emergence of two new terms «ER Low Positive¼ and «HER2 Low¼ to characterize tumors with low expression of estrogen receptors and HER2.

[Investigation of the mutational status of the FGFR3 gene in urothelial bladder carcinoma]. / Issledovanie mutatsionnogo statusa gena FGFR3 v urotelial'noi kartsinome mochevogo puzyrya.

OBJECTIVE: To study the somatic mutational status of the FGFR3 gene in urothelial bladder cancer (BC) and evaluate its relationship with the clinical and morphological characteristics of the tumor, deficiency of the DNA mismatch repair (dMMR), PD-L1 tumor status, and immunohistochemical (IHC) expression of the p16 protein. MATERIAL AND METHODS: Surgical material of 40 patients with BC, on which the mutational status of the FGFR3 gene was studied using the molecular genetic method, as well as the MMR status, PD-L1 and p16 expression by the IHC method. RESULTS: FGFR3 mutations, such as G370C, S249C, S371C/Y373C, R248C, were detected in 35.0% of the studied BC samples. FGFR3 status did not depend on the gender and age of patients, as well as on the degree of tumor lymphoid infiltration (TILs). Statistically significant differences were found in the analysis of FGFR3 status depending on the histological structure and degree of tumor differentiation, as well as on the pT stage. The FGFR3 status of BC was not associated with the IHC expression of the studied proteins of the MMR system, as well as with the PD-L1 status. Higher levels of PD-L1 expression were demonstrated by BC tumor cells, in which no aberrations in FGFR3 were detected. There was no significant association between p16 status and the presence of FGFR3 mutations, but for FGFR3-positive carcinomas, the basal pattern of p16 staining by IHC was noted. CONCLUSION: A positive somatic mutational status of the FGFR3 gene was statistically significantly more common in the group of papillary low-grade non-muscle-invasive BC, demonstrating basal p16 IHC staining. In the study sample, there was no statistically significant relationship between the FGFR3 status of BC and gender and age differences, TILs, MMR status, PD-L1 status (SP142 and 22C3), and p16 status. The results of the study indicate the need to determine the FGFR3 status in patients with BC for further prescription of personalized therapy.

[External quality control of immunohistochemical studies in pathomorphology: tasks, problems, solutions, development prospects]. / Vneshnii kontrol' kachestva immunogistokhimicheskikh issledovanii v patomorfologii: zadachi, problemy, puti resheniya, perspektivy razvitiya.

In 2022, the Quality Control Center for Immunohistochemical Studies of the Russian Medical Academy of Continuing Professional Education conducted 12 rounds of markers for breast, lung, prostate, bladder cancer with the participation of 83 laboratories. For the first time, a round was held to control the method of in situ hybridization in the diagnosis of breast cancer, and a digital round. Typical problems in carrying out immunohistochemical studies in oncomorphology have been identified and the importance of participation of laboratories in external control has been shown.

[Results of the work of the Russian Medical Academy of Continuous Professional Education Center for quality control of immunohistochemical studies for 2019-2021]. / Itogi raboty Tsentra kontrolya kachestva immunogistokhimicheskikh issledovanii FGBOU DPO «RMANPO¼ za 2019­2021 gg.

In 2019-2021 the Russian Medical Academy of Continuous Professional Education Center for quality control of immunohistochemical studies conducted rounds on the most used tumour markers of various localizations. The deficiencies in the conduct of immunohistochemical studies were identified and the importance of the participation of medical organizations in measures to improve the quality control of immunohistochemical studies in oncomorphology was shown.

[Reed nevus and cutaneous melanoma in children: an immunohistochemical study]. / Nevus Rida i melanoma kozhi u detei. Immunogistokhimicheskoe issledovanie.

Certain difficulties arise in the differential diagnosis between Reed nevus that is common in children and adolescents and cutaneous melanoma that is extremely rare in patients of this age group. In addition to the classical histological examination, an immunohistochemical test for marker proteins is carried out to improve the accuracy of the diagnosis of pigmented skin neoplasms. OBJECTIVE: To evaluate the suitability of a set of proteins (cyclin D1, p16INK4a, and HLA class I antigens) in the differential diagnosis of Reed nevus and cutaneous melanoma in children and adolescents. MATERIAL AND METHODS: Three samples of pigmented skin neoplasms were taken during surgical treatment in patients at the Blokhin National Medical Research Center of Oncology: two samples of Reed nevus (from a 9-year-old girl and a 15-year-old boy) and a sample of cutaneous melanoma that had developed in an 8-year-old boy. The materials were presented by paraffin blocks. Immunohistochemical staining was performed using antibodies against cyclin D1, p16INK4a, and HLA class I antigens. RESULTS: Differences were found between nevus and melanoma in the expression of all three markers. Thus, the nuclear expression of cyclin D1, a proliferation activator, occurred in some cells in the nevus samples and in the vast majority of cells in the melanoma samples. The nuclear expression of the cell cycle inhibitor p16INK4a was dramatically reduced in melanoma compared to nevus. HLA class I antigens were detected on the surface of individual nevus cells, but were completely absent on the membranes and in the cytoplasm of melanoma cells, which could promote the evasion of this tumor from the body's immunological supervision. CONCLUSION: Immunohistochemical test for the proteins cyclin D1, p16INK4a, and HLA class 1 antigens is a promising approach to differentially diagnosing between Reed nevus and cutaneous melanoma in children and adolescents.

[Immunohistochemical study of MSI markers in breast cancer]. / Immunogistokhimicheskoe issledovanie markerov MSI pri rake molochnoi zhelezy.

OBJECTIVE: To investigate the expression of microsatellite instability (MSI) markers, which is detected by an immunohistochemical technique, and to compare the expression with the PD-L1 status in luminal B, HER2-negative and triple-negative breast cancer. MATERIAL AND METHODS: The investigation included tumors from 40 patients with triple-negative and luminal B, HER2-negative subtypes. Immunohistochemical study was performed using Ventana antibodies: anti-MLH1 (clone M1), anti-MSH2 (clone G219-1129), anti-PMS2 (clone A16-4), and anti-MSH6 (clone SP93). MSI was assessed according to the standard criteria. RESULTS: The PD-L1-positive status was present in 14 (35%) of the 40 patients. Moreover, MSI-H was detected in only 1 (2.50%) case. The two-year survival rate was 87.5%; it should be noted that the median survival rate was not reached either in the study sample or in the groups divided according to PD-L1 and MSI statuses. The overall survival rate for patients with MSI was 75% (3/4). CONCLUSION: The first comparative study of the expression of PD-L1 and immunohistochemical MSI markers, which has been conducted on a small sample, fails to draw unambiguous conclusions, but shows the need to investigate this phenomenon on large samples and by using genetic methods.

[The first experience of PD-L1 testing of triple negative breast cancer with marker SP142 in Russia]. / Pervyi opyt PD-L1-testirovaniya troinogo negativnogo raka molochnoi zhelezy markerom SP142 v Rossii.

AIM OF STUDY: To evaluate the pecularities of PD-L1 expression in triple negative breast cancer (TNBC) in the Russian population. MATERIALS AND METHODS: For 7 months, within a scientific study of the Russian Society of Clinical Oncology (RUSSCO), we determined the PD-L1 status of 58 patients with TNBC. In each case, an immunohistochemical study was performed in a closed Ventana Bench Mark Ultra automatic stainer using a closed protocol with rabbit monoclonal antibodies Ventana PD-L1 SP142 and Opti View DAB IHC Detection Kit with Opti View Amplification Kit. RESULTS: Positive PD-L1 status in TNBC was detected in 37.93% of cases. Almost all tumors had an expression level of up to 10%. Only 5.17% of cases showed ligand expression on tumor cells. CONCLUSIONS: According to the results of the first experience of testing PD-L1 in TNLM in Russia, it was possible to obtain data comparable to the same data of large international studies. RUSSCO's information and logistic support allows making this analysis available to all citizens of the country.

[Immunohistochemical study of the MSI phenotype of urothelial bladder cancer]. / Issledovanie MSI-fenotipa urotelial'nogo raka mochevogo puzyria immunogistokhimicheskim metodom.

OBJECTIVE: To investigate the MSI phenotype of urothelial bladder cancer (BC) by immunohistochemistry (IHC) and to assess its relationship to the prognostic factors of the disease and PD-L1 status of BC. MATERIAL AND METHODS: Using the surgical and biopsy materials obtained from 50 patients with BC during examination and treatment, the investigators studied the MSI phenotype by IHC. A system was proposed to assess the IHC expression of MSI proteins, by taking into account the intensity of nuclear staining and the area occupied by tumor cells with stained nuclei. RESULTS: An analysis of the results of an IHG study of MSI protein expression revealed a high direct correlation between the nuclear staining intensity of tumor cells and the percentage of tumor area occupied by the latter. The lack/decrease of the expression of the studied proteins was associated with the stage (T) and the presence of a high-grade tumor. The heterogeneous expression of the studied proteins (PMS2, MLH1, and MSH6) was noted to be 10, 30, and 40%, respectively. CONCLUSION: A high direct correlation was observed between the nuclear staining intensity of tumor cells and the percentage of the area occupied by the latter. There was a relationship between the lack and/or decrease of the expression of MSI proteins (mainly PMS2 and MLH1 and to a lesser extent MSH6) and the grade of BC, as well as stage T; there was a tendency to decrease the expression of the studied proteins in the area of invasive tumor growth, which confirms the prognostic role of MSI proteins. The most pronounced heterogeneity of IHC expression was noted with MSH6; the least one was seen with PMS2. There was a predominance of high-grade surface carcinomas (T1) among the heterogeneously stained tumors. In the case of positive PD-L1 status, there was decreased PMS2 and MLH1 expression and pronounced MSH6 expression; no significant relationship was found due to the small number of these cases. The authors consider it necessary to conduct further studies of the relationship between the MSI phenotype and the PD-L1 status of BC.

[Study of the PD-L1 status in breast cancer, by using the SP142 monoclonal antibody, and the prospects for determining treatment policy]. / Issledovanie PD-L1-statusa raka molochnoi zhelezy s ispol'zovaniem monoklonal'nogo antitela SP142 i perspektivy dlia opredeleniia lechebnoi taktiki.

OBJECTIVE: To investigate the expression of programmed death ligand 1 (PD-L1) in triple-negative and luminal B, HER2-negative breast cancer, by using the SP142 antibody and to assess the association of the PD-L1 status with prognosis for patients. MATERIAL AND METHODS: The study was conducted using surgical materials (full sections) obtained from 72 patients. The sections were stained with the SP142 PD-L1 antibody. RESULTS: Differences were found in the detection rates of the PD-L1-positive status in the primary tumor and regional metastasis (primary tumor in 26 (36.1%) cases and metastasis in 18 (47.4%) of the 38 cases). By and large, the PD-L1-positive status was less common in the patients receiving neoadjuvant chemotherapy (25.8% versus 53.7%); however, it should be noted that the PD-L1-positive status was more often detected in those who had a higher residual cancer burden (RCB) (RCB-III versus RCB-II). CONCLUSION: Considering the findings, it is necessary to clarify the status of not only a primary focus, but also clinically significant metastases, especially if the primary tumor has yielded a negative result. The patients with disease progression who receive standard therapy regimens may have a chance for a good result when using PD-1/PD-L1 blockers. At the same time, the association of the PD-L1 status with RCB may affect the choice of adjuvant treatment policy.

[PD-L1 status in breast cancer]. / PD-L1-status raka molochnoi zhelezy.

OBJECTIVE: To investigate the expression of PD-L1 in triple-negative and luminal B, HER2-negative breast carcinoma and to assess the association of the tumor PD-L1 status with the prognosis of the disease. SUBJECT AND METHODS: The PD-L1-status of primary tumor was studied in 72 patients with breast cancer, by using an immunohistochemical method. RESULTS: Differences were found in the incidence of carcinomas with PD-L1 expression in tumor cells depending on the molecular genetic type: there was a positive PD-L1 status in luminal B, HER2-negative tumors in 4 (14.81%) of 27 cases and in triple-negative tumors in 17 (37.78%) of 45 cases. An analysis of tumors after neoadjuvant therapy revealed a positive PD-L1-status in tumor cells in 1 of 18 patients with a moderate residual tumor load and in 6 of 13 with a high residual tumor load (5.56 and 46.15%, respectively), as estimated by the RCB system. CONCLUSION: The positive PD-L1 status in triple-negative breast cancer was determined more than 2 times as frequently as in luminal B, HER2-negative breast cancer (37.78 and 14.81%). There was a considerable correlation between the high residual tumor load and the positive tumor PD-L1 status.

[Comprehensive assessment of the content of polycyclic aromatic hydrocarbons and dependence of their accumulation in meat products].

Dependences of the quantity of polycyclic aromatic hydrocarbons (PAH) on the conditions for the formation of components of smoke compositions, the type of wood, the formulation, the technology of production, and the type of packaging material have been studied. An increase in temperature from 450 to 700 °C lead to a 2-3-fold increase in the amount of PAH in meat products. It has been established that the use of a polyamide coating reduced the total carcinogenicity of sausages by 2.0-3.7 fold compared with protein and natural shells, which in terms of PAH accumulation were the most dangerous. Fibrous shell was able to provide a reduction in PAH level in the product up to 40% compared to natural one. The permeability of the fat fraction of the product for PAH was up to 10 fold higher than that of proteins and carbohydrates. The data obtained made it possible to determine the safety criteria for smoked meat products, taking into account the potential carcinogenic hazard of each PAH. The optimal indicators of the presence of PAH in the product are 8 PAH (benz[a]pyrene, chrysene, benz[a]anthracene, benzo[b]fluoranthene, benzo[k]fluoranthene, benzo[g,h,i]perylene, dibenz[a,h]anthracene, indeno[1,2,3-c,d] pyrene). The PAH exposure on the human body has been determined under the constant consumption of smoked meat products. The prospective use of barrier protection technologies, substances possessing antiradical activity, and protective films to reduce residual PAH content has been proved. The results of the studies showed a 5-fold decrease in the total amount of PAH when using films impregnated with fat-containing micro anemulsion of vegetable or animal fat. The effect increased when meat was marinateв in a 9% solution of acetic acid or 3% solution of ascorbic acid.

[CHARACTERISTICS OF THE CONDITION OF FULL-TERM NEWBORNS FROM THE GROUP OF HIGH PERINATAL RISK DURING VACCINATION PERIOD IN THE MATERNITY HOSPITAL].

AIM: Evaluation of the volume of immune prophylaxis work at the stage of administering aid to newborns at the early neonatal period. MATERIALS AND METHODS: Case-control type cohort retro- spective study was carried out, 160 medical reports of deliveries and histories of development of illness of newborns during the period of March-October 2014 were analyzed. Statistical treatment of data was carried out using Statistica 7.0 package. RESULTS: Principal nosologic units in pregnant women and their newborn children, volumes of primary vaccination (against viral hepatitis B, tuberculosis) in maternity hospitals in children with perinatal pathology and healthy newborns, reasons for medical counterindications,were determined. CONCLUSION: The process of vaccination in perinatal center has its own features: a high amount of medical counterindications and thus a low coverage of primary vaccination of newborns, not exceeding 40%. Each child requires indi- vidual approach, the question of sequence and calendar of vaccination is solved taking into con- sideration the health condition. Healthy newborns are vaccinated according to the national vac- cination calendar except those children whose parents reject vaccination.

[Method of determination organic iodine (iodotyrosines) in food].

It is important to control the substances of the synthesis of biologically active supplements, based on organic forms of iodine (iodotyrosines). But it is no less important to control the content of iodotyrosines in foods. The developed method is sensitive and selective and can determine iodotyrosines with a lower limit of detection (1 ppb). Iodotyrosines have been determined by HPLC-MS/MS. The article contains parameters for chromatographic separation of 3-iodo-L-tyrosine and 3.5-diiodo-L-tyrosine and parameters of the electrospray ionization (ESI) mass spectrometry, describes the methodology of sample preparation and solid phase extraction. The article substantiates the use of mass spectrometry as the most sensitive and selective method for determining the organic iodine as compared to HPLC with UV detection. The enzymatic hydrolysis with proteolytic enzymes has been used for sample preparation in iodothyronine analyses. Solid phase extraction was performed using C18 cartridge. For HPLC-MS/MS analysis iodothyronine derivatives were obtained with a mixture of butanol-acetyl chloride. Degree of iodotyrosine extraction from the matrix of the foodstuffs was not less than 85%, the correlation coefficient of the calibration curve in the concentration range of 1-2000 ng/mL was 0.999, reliable determination of iodine content in foods in the range from 10 to 20 000 mcg/kg.

[Comparative study of the determination of the HER2 status in gastric cancer in the biopsy and intraoperative specimens].

OBJECTIVE: To determine the HER2 status of gastric adenocarcinomas, by using biopsy and intraoperative specimens. SUBJECTS AND METHODS: Immunohistochemistry and in situ hybridization were used to examine the HER2 status of 346 gastric cancer biopsy and intraoperative specimens. RESULTS: The study conducted on a large Russian sample of 346 patients showed a positive HER2 status in 10.7% of the examined specimens. Intestinal-type adenocarcinomas exhibited a positive HER2 status in 21.4% of the cases. Comparative analysis of the HER2 status in the biopsy and intraoperative specimens indicated that there were differences in the determination of the tumor HER2 status in less than 1% of the examined specimens. The remaining found differences (14.7%) failed to change the tumor HER2 status and to affect the choice of a treatment regimen. CONCLUSION: The performed investigation has demonstrated that the tumor HER2 status determined in the biopsy specimen significantly reflects the molecular biological properties of gastric cancer and may be clinically used to determine indications for the use of targeted drugs.

[The comparative analysis of changes of short pieces of EEG at perception of music on the basis of the event-related synchronization/desynchronization and wavelet-synchrony].

The going of present pilot study is an analysis of features changes of EEG short pieces registered from 32 sites, at perception of musical melodies healthy examinees depending on logic (cognizance) and emotional (it was pleasant it was not pleasant) melody estimations. For this purpose changes of event-related synchronization/desynchronization, and also wavelet-synchrony of EEG-responses at 31 healthy examinees at the age from 18 till 60 years were compared. It is shown that at a logic estimation of music the melody cognizance is accompanied the event-related desynchronization in the left fronto-parietal-temporal area. At an emotional estimation of a melody the event-related synchronization in left fronto - temporal area for the pleasant melodies, desynchronization in temporal area for not pleasant and desynchronization in occipital area for the melodies which are not causing the emotional response is typical. At the analysis of wavelet-synchrony of EEG characterizing jet changes of interaction of cortical zones, it is revealed that the most distinct topographical distinctions concern type of processing of the heard music: logic (has learned-hasn't learned) or emotional (it was pleasant-it was not pleasant). If at an emotional estimation changes interhemispheric communications between associative cortical zones (central, frontal, temporal), are more expressed at logic - between inter - and intrahemispheric communications of projective zones of the acoustic analyzer (temporal area). It is supposed that the revealed event-related synchronization/desynhronization reflects, most likely, an activation component of an estimation of musical fragments whereas the wavelet-analysis provides guidance on character of processing of musical stimulus.

[Possibilities of wavelet-syncronization method for estimation of the spatial distribution of components of auditory evoked potentials in healthy subjects].

Event-related potentials (ERP) are informative indicators of higher nervous activity of healthy people and patients in pathological states. Traditionally, methods of ERP processing include peak-time characteristics, topographical mapping and localization of equivalent dipole sources. At the same time, estimation of ERP synchronization is complicated by a short duration of the process. The wavelet analysis makes it possible to overcome the disadvantages of the traditional Furrier analysis and to calculate characteristics of ERP synchronization, in particular, phase synchronization. A new approach to estimation of the auditory ERP in healthy persons is proposed in the article. The method is based on the analysis of phase wavelet-synchronization of ERP individual components under conditions of differentiation of different degrees of attention concentration in healthy persons.

[Amplitude-time parameters of long-latency components (N1, N2 and P300) of acoustic evoked potential of healthy examinees of young and mature age].

The aim of study was to track a cumulative changes of amplitude-time parametres of components N1, N2 and P300 of acoustic evoked potential in experimental situations different in complexity (at the account and listening of sounds) and to compare the received distinctions at examinees of young and mature age. ERP were recorded at 12 healthy subjects from 18 to 22 ages and 12 subjects from 32 to 59 ages. The two-stimuli oddball paradigm was used. It is revealed that components N1, N2 and P300 recorded in the situation of the listenings of sounds without any preliminary instruction do not differ at persons of young and mature age. At examinees of younger age the biger amplitude of component N1 is noted at the account of sounds in comparison with listening whereas the latency of the one do not change depending on complexity of the task. It is shown that component N2 has stability of latency in relation to age and an experimental situation. The amplitude of component N2 is above at the account of sounds in both age groups. The amplitude-time parametres of component P300 do not differ at examinees of different age in a problem of listening of sounds. The revealed features of components N1, N2 and P300 at examinees of young and mature age in experimental situations different in complexity, allow to assume that with the years at the person adaptive mechanisms which allow carrying out successfully of the task.